MED Medartis Holding AG
Medartis Holding AG, a medical device company, engages in the development, manufacturing, and sales of implant solutions worldwide. The company's medical devices are used for the treatment of surgical fixation of bone fractures for upper and lower extremities, as well as for the cranio-maxillofacial surgery. It provides products for the hand, wrist, forearm, elbow, shoulder, and foot and ankle, as well as for upper and lower extremities, mandible, midface, orthognathic under the APTUS and MODUS names, as well as CMX services through web portal, and kerimedical products. The company was incorporated in 1997 and is headquartered in Basel, Switzerland.…
Industry Peers
Medical DevicesKey Statistics
About Medartis Holding (SWX: MED)
›
Medartis Holding (SWX: MED) is listed on the SIX Swiss Exchange, where its shares trade in CHF. It belongs to the Medical Devices industry, part of the Healthcare sector, and reports about 1,428 employees.
The shares were at 114.80 CHF on 19 November 2026, up 52.9% over 52 weeks. Its 52-week range is 70.60 CHF to 115.20 CHF, and it trades at the top of that range.
At a market capitalisation of 1.43B CHF, it trades at 95.7 times trailing earnings and 48.3 times forward earnings. The median trailing P/E of its 19 largest Medical Devices peers is 25.6, a premium of 273% for MED.
Medartis Holding reports return on equity of 3.0%, an operating margin of 2.9% and revenue up 30.7% year over year.
Its debt exceeds its cash by 181.45M CHF, a debt-to-equity ratio of 0.57. Its Piotroski F-score is 5 out of 9, an average reading of its financial health. 4 analysts cover the stock, with an average rating of Strong Buy; their mean price target of 123.75 CHF is 7.8% above the current price. The next earnings report is expected on 16 March 2027.